期刊文献+

PPARγ对人胰腺癌细胞中抑癌基因PTEN表达的影响 被引量:3

下载PDF
导出
摘要 目的:观察PPARγ对人胰腺癌细胞中抑癌基因PTEN表达的影响。方法:采用体外培养人胰腺癌细胞株PANC-1,使用罗格列酮、GW9662细胞处理,运用RT—PCR检测PANC-1细胞中的PTEN基因变化情况。结果:PPARγ激动剂罗格列酮可诱导抑癌基因PTEN的高表达,随着罗格列酮浓度增加,表达也逐渐增强。结论:胰腺癌细胞中PPARγ的表达和抑癌基因PTEN的表达呈一致性,PPARγ可能是通过一定信号的转导通路来调节抑癌基因PTEN的表达,以发挥抗肿瘤的作用。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第8期828-829,共2页 Chinese Journal of Cellular and Molecular Immunology
  • 相关文献

参考文献3

二级参考文献10

  • 1C.W迪芬巴赫 G.S德维克斯勒.PCR技术实验指南(第1版)[M].北京:北京科学出版社,1998.64.
  • 2Smith MR,Kantoff PW.Peroxisome proliferator-activated receptor gamma ( ppar gamma) as a novel target for prostate cancer[J].Invest New Drugs,2002,20:195 - 200
  • 3Tontonoz P,Singer S,Forman B M,et al.Terminal differentiation of human liposarcoma cells induced by ligands for Peroxisome proliferator-actived receptors-γ and retinoid X receptor [J].Proc Natl Acad Sci USA,1997,94:237 - 241
  • 4Demetri GD,Fletcher CD,Mueller E,et al.Induction of solid tumor differentiation by the peroxisome proliferator-actived receptors-γ ligand troglitazone in patients with liposarcoma [J].Proc Natl Acad Sci USA,1999,96:3951 - 3956
  • 5Koeffler HP.Peroxisome proliferator-activated receptor gamma and cancers[J].Clin Cancer Res,2003,9:1 -9
  • 6Inoue K,Kawahito Y,Tsubouchi Y,et al.Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists [J].Biochem Biophys Res Commun,2001,287:727 - 732
  • 7Kliewer SA,Sundseth SS,Jones SA,et al.Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator activated receptors β and γ[J].Proc Natl Acad Sci USA,1997,94:4318-4323
  • 8Theocharisa S,Margeli A,Kouraklis G.Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents [J].Curr Med Chem Anti Canc Agents,2003,3:239 -251
  • 9Elstner E,Muller C,Koshizuka K,et al.Ligands for Peroxisome proliferator activated receptor and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice[J].Proc Natl Acad Sci USA,1998,95:8806 -8811
  • 10Roberta Caruso,Francesco Pallone,Giovanni Monteleone.Emerging role of IL-23/IL-17 axis in H pylori-associated pathology[J].World Journal of Gastroenterology,2007,13(42):5547-5551. 被引量:20

共引文献32

同被引文献38

  • 1邵根宝,贾超,刘红林,赵茹茜,丁红梅,陈杰,黄瑞华,徐银学.与PPAR基因连锁的5个微卫星标记与猪肉质性状的相关性[J].农业生物技术学报,2006,14(2):162-165. 被引量:9
  • 2刘尊敬,杨期东,刘运海,王国相,焦劲松,田朝晖,龙涛,徐文艳.PPARγ激活剂对大鼠缺血再灌注脑组织的保护作用及对PPARγ表达的影响[J].中风与神经疾病杂志,2007,24(2):132-135. 被引量:16
  • 3Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127 (12) : 2893 -2917.
  • 4Reka AK, Goswami MT, Krishnapuram R, et 81. Molecular cross- regulation between PPAR-',/ and other sigmding pathways: implications for lung cancer therapy[J]. Lung Cancer, 2011,72(2) : 154 - 159.
  • 5Psyrri A, Arkadopoulos N, Vassilakopoulou M, et al. Pathways andtargets in hepatocellular carcinoma[ J]. Expert Rev Antieancer Ther, 2012, 12(10): 1347-1357.
  • 6Shen B, Chu ES, Zhao G, et al. PPARganmm inhibits hepatoceUular carcinoma metastases in vitro and in mice[ J]. Br J Cancer, 2012, 106 (9) : 1486 - 1494.
  • 7Mosca E, Bareella M, Alfieri R, et al. Systems biology of the metabolic network regulated by the Akt pathway[ J]. Biotechnol Adv, 2012, 30 (1): 131 -141.
  • 8Hafsi S, Pezzino FM, Candido S, et al. Gene alterations in the PI.3K/PTEN/AKT pathway as a mechanism of drug-resistance (review) [J]. Int J Oncol, 2012, 40(3) : 639 -644.
  • 9Chan CH, Morrow JK, Li CF, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression[J]. Cell, 2013, 154(3) : 556 -568.
  • 10Mitrea DM, Yoon MK, Ou L, et al. Disorder-function relationships for the cell cycle regulatory proteins p21 and p27 [ J]. Biol Chem, 2012, 393(4) : 259 -274.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部